Validation of a kinetic model for receptor-mediated uptake of Tc-99m-galactosyl-neoglycoalbumin (Tc-NGA)

Tc-NGA is a receptor-binding radiopharmaceutical which localizes specifically to the liver. The rate of uptake depends upon: 1) Tc-NGA-receptor affinity, k/sub b/, 2) molar dose, L/sub e/(O), and 3) hepatic blood flow, Q. The authors have proposed a kinetic model which describes hepatic uptake in terms of measurable physiochemical quantities: Q, k/sub b/, R, V/sub e/, V/sub h/ (systemic and liver blood volumes), and V/sub r/ (liver plasma volume). Computer simulations were compared to kinetic data (ROIs: precordium and liver, 420 data pts) resulting from injection into pigs (n=12) of Tc-NGAs of differing k/sub b/(0.6,1.2,1.8 x 10/sup 5/ M/sup -1/sec/sup -1/). Each pig was studied twice using different molar doses (0.5 - 10. x 10/sup -8/mole). Measurements of V/sub e/ (Tc-RBCs) and Q (indocyanine green extraction) were obtained during each study. Weights of excised livers were used to calculate V/sub h/ and r. With exception of the low-dose, low-affinity studies, all data was fit to within a reduced chi-square of 3 by adjustment of 1/sub e/, 1/sub h/, c, α/sub m/ and the σs. The authors conclude that this model is a valid description of a receptor-binding process, however competition by endogenous ligand may prevent its use at low molar doses of low-k/sub b/ NGA